The report is titled as ‘Ezetimibe Drug Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the ezetimibe drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Ezetimibe drugs market is expected to grow with significant rate in the near future.
The global ezetimibe drug market in 2020 is estimated for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of 8.9%.
Ezetimibe Drug Market Definition
Ezetimibe is the first-in-class of novel selective cholesterol-absorption inhibitor pending approval in the U.S. Ezetimibe selectively inhibits the uptake of cholesterol from the intestinal lumen at the level of the enterocyte in the intestinal brush border but shows no effects on the absorption of other sterols or lipid-soluble vitamins.
Ezetimibe is found to reduce the level of low-density lipoprotein cholesterol (LDL-C) by approximately 15 to 20%. Unlike other lipid-lowering drugs, ezetimibe does not found to produce hypertriglyceridemia as side effect.
Ezetimibe is being evaluated in clinical trials as a monotherapy in patients who need modest reductions in LDL-C or are intolerant to other lipid-lowering medication, and in combination with a statin in patients who are unable to tolerate large doses of statins or need further reductions in LDL-C.
Ezetimibe Drug Market Dynamics
The increasing prevalence of obesity and hypercholesterolemia creates huge opportunities for growth of the ezetimibe market, subject to the launch of drugs in the U.S. According to a study in The Journal of the American Medical Association (JAMA), the obesity rate among adult Americans was estimated at 32.2% for men and 35.5% for women. This creates a large patient pool for the drug. However, the long-term safety and the effect on cardiovascular morbidity and mortality of ezetimibe are unknown.
Ezetimibe Drug Market Key Players
Global ezetimibe drug market is dominated by Allergan Plc., Sivem Pharmaceuticals Plc., Sanis Health Inc., Pro Doc Limited, Sun Pharmaceuticals ltd, Merck, Teva Pharmaceuticals Industries Ltd. etc. among others.
Ezetimibe Drug Market Segmentation
The global ezetimibe drug market is segmented on the basis of distribution channel, and region. Based on distribution channel global ezetimibe drug market is segmented into hospital pharmacy, retail pharmacy, drug store, online prescription stores etc.
The global ezetimibe drug market is expected to increase at a robust CAGR over the forecast period owing to increasing production of fish oil and growing clinical applications of fish oil.
Ezetimibe Drug Market Regional Overview & Analysis
On the basis of region, the global ezetimibe drug market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America ezetimibe drug market is expected to be the most dominating market throughout the forecast period due to the growing prevalence of obesity and hypercholesterolemia. Europe is expected to be the second-largest market due to the early launch of drugs in the region.
MMC Overview on Ezetimibe Drug Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Ezetimibe Drug market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Ezetimibe Drug
• Advantages of Ezetimibe Drug
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Ezetimibe Drug Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Ezetimibe Drug Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Ezetimibe Drug Market Snapshot
2.4. Global Ezetimibe Drug Market Size and Forecast, 2019–2027
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)
2.5. Global Ezetimibe Drug Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Ezetimibe Drug Market, By Distribution Channel
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Distribution Channel
3.1.2. BPS Analysis, By Distribution Channel
3.2. Market Revenue (US$Mn) Forecast, By Distribution Channel
3.2.1. Hospital Pharmacy
3.2.2. Retail Pharmacy
3.2.3. Drug Store
3.2.4. Online Prescription Stores
3.3. Global Ezetimibe Drug Market Attractiveness Index, By Distribution Channel
4. Global Ezetimibe Drug Market, By Region
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Region
4.1.2. BPS Analysis, By Region
4.2. Market Revenue (US$Mn) Forecast, By Region
4.2.1. North America
4.2.2. Latin America
4.2.3. Europe
4.2.4. Asia Pacific
4.2.5. Middle East and Africa
4.3. Global Ezetimibe Drug Market Attractiveness Index, By Region
5. North America Ezetimibe Drug Market Analysis and Forecast, 2019–2027
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Country
5.1.2. BPS Analysis, By Country
5.2. Market Revenue (US$Mn) Forecast, By Country
5.2.1. U.S. Ezetimibe Drug Market
5.2.2. Canada Ezetimibe Drug Market
5.3. North America Ezetimibe Drug Market, By Distribution Channel
5.3.1. Hospital Pharmacy
5.3.2. Retail Pharmacy
5.3.3. Drug Store
5.3.4. Online Prescription Stores
5.4. North America Ezetimibe Drug Market Attractiveness Index
5.4.1. By Country
5.4.2. By Distribution Channel
6. Latin America Ezetimibe Drug Market Analysis and Forecast, 2019–2027
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market (US$Mn) Forecast, By Country
6.2.1. Brazil Ezetimibe Drug Market
6.2.2. Mexico Ezetimibe Drug Market
6.2.3. Argentina Ezetimibe Drug Market
6.2.4. Rest of Latin America Ezetimibe Drug Market
6.3. Latin America Ezetimibe Drug Market, By Distribution Channel
6.3.1. Hospital Pharmacy
6.3.2. Retail Pharmacy
6.3.3. Drug Store
6.3.4. Online Prescription Stores
6.4. Latin America Ezetimibe Drug Market Attractiveness Index
6.4.1. By Country
6.4.2. By Distribution Channel
7. Europe Ezetimibe Drug Market Analysis and Forecast, 2019–2027
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) Forecast, By Country
7.2.1. U.K. Ezetimibe Drug Market
7.2.2. Germany Ezetimibe Drug Market
7.2.3. Italy Ezetimibe Drug Market
7.2.4. France Ezetimibe Drug Market
7.2.5. Spain Ezetimibe Drug Market
7.2.6. Russia Ezetimibe Drug Market
7.2.7. Poland Ezetimibe Drug Market
7.2.8. BENELUX Ezetimibe Drug Market
7.2.9. NORDIC Ezetimibe Drug Market
7.2.10. Rest of Europe Ezetimibe Drug Market
7.3. Europe Ezetimibe Drug Market, By Distribution Channel
7.3.1. Hospital Pharmacy
7.3.2. Retail Pharmacy
7.3.3. Drug Store
7.3.4. Online Prescription Stores
7.4. Europe Ezetimibe Drug Market Attractiveness Index
7.4.1. By Country
7.4.2. By Distribution Channel
8. Asia Pacific Ezetimibe Drug Market Analysis and Forecast, 2019–2027
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. China Ezetimibe Drug Market
8.2.2. India Ezetimibe Drug Market
8.2.3. Japan Ezetimibe Drug Market
8.2.4. Australia and New Zealand Ezetimibe Drug Market
8.2.5. South Korea Ezetimibe Drug Market
8.2.6. ASEAN Ezetimibe Drug Market
8.2.7. Rest of Asia Pacific Ezetimibe Drug Market
8.3. Asia Pacific Ezetimibe Drug Market, By Distribution Channel
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy
8.3.3. Drug Store
8.3.4. Online Prescription Stores
8.4. Asia Pacific Ezetimibe Drug Market Attractiveness Index
8.4.1. By Country
8.4.2. By Distribution Channel
9. Middle East Ezetimibe Drug Market, By Region
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. GCC Countries Ezetimibe Drug Market
9.2.2. Israel Ezetimibe Drug Market
9.2.3. Oman Ezetimibe Drug Market
9.2.4. Rest of Middle East Ezetimibe Drug Market
9.3. Middle East Ezetimibe Drug Market, By Distribution Channel
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy
9.3.3. Drug Store
9.3.4. Online Prescription Stores
9.4. Middle East Ezetimibe Drug Market Attractiveness Index
9.4.1. By Country
9.4.2. By Distribution Channel
10. Africa Ezetimibe Drug Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. South Africa Ezetimibe Drug Market
10.2.2. Egypt Ezetimibe Drug Market
10.2.3. North Africa Ezetimibe Drug Market
10.2.4. Rest of Africa Ezetimibe Drug Market
10.3. Africa Ezetimibe Drug Market, By Distribution Channel
10.3.1. Hospital Pharmacy
10.3.2. Retail Pharmacy
10.3.3. Drug Store
10.3.4. Online Prescription Stores
10.4. Africa Ezetimibe Drug Market Attractiveness Index
10.4.1. By Country
10.4.2. By Distribution Channel
11. Recommendation
11.1. Market Strategy
12. Competitive Landscape
12.1. Competition Dashboard
12.2. List and Company Overview of Global Key Players
12.3. Company Profiles
12.3.1. Allergan Plc.
12.3.1.1. Company Overview
12.3.1.2. Financial Overview
12.3.1.3. Product Portfolio
12.3.1.4. Key Developments
12.3.1.5. Business Strategies
12.3.2. Sivem Pharmaceuticals Plc
12.3.3. Sanis Health Inc
12.3.4. Sun Pharamaceuticals Ltd.
12.3.5. Glenmark Pharma
12.3.6. Merck
12.3.7. Teva Pharmaceutical Industries Ltd..
12.3.8. Pro Doc Limited
13. Acronyms
Frequently Asked Questions
What includes in distribution channels segment of the market?
Based on distribution channel global ezetimibe drug market is segmented into hospital pharmacy, retail pharmacy, drug store, online prescription stores etc.
What are the key factors driving the growth of market?
The increasing prevalence of obesity and hypercholesterolemia creates huge opportunities for growth of the ezetimibe market
What segments are covered in market report?
The global ezetimibe drug market is segmented on the basis of distribution channel, and region.
What are the key participating players in the market?
Global ezetimibe drug market is dominated by Allergan Plc., Sivem Pharmaceuticals Plc., Sanis Health Inc., Pro Doc Limited, Sun Pharmaceuticals ltd, Merck, Teva Pharmaceuticals Industries Ltd. etc. among others.
